Planning and analysis of repeated measures at key time-points in clinical trials sponsored by pharmaceutical companies.

In this paper we explore the possible reasons why medical papers reporting clinical trials sponsored by the pharmaceutical industry often analyse repeated measures data at certain key time-points instead of employing sophisticated models of repeated measures proposed by many statisticians. A survey indicated that the priority reason in the industry for having repeated measures in clinical trials is to monitor the trial and to utilize the early results for strategic decision making. We discuss what the common statistical methods do and do not offer for analysis of repeated measures in such clinical trials. We advocate the need to improve the understanding of the medical interest in conducting longitudinal trials in the industry, and to plan and analyse the repeated measures accordingly. We address the medical interest by formulating the problem and give illustrative examples for both phases II and III trials.

[1]  D. N. Geary.  Sequential testing in clinical trials with repeated measurements , 1988 .

[2]  N M Laird,et al.  Estimating rates of change in randomized clinical trials. , 1990, Controlled clinical trials.

[3]  D G Altman,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[4]  J. Lachin.  Group sequential monitoring of distribution-free analyses of repeated measures. , 1997, Statistics in medicine.

[5]  M. Nunn,et al.  Prognosis versus actual outcome. II. The effectiveness of clinical parameters in developing an accurate prognosis. , 1996, Journal of periodontology.

[6]  W. Shih,et al.  Sample Size and Power Calculations for Periodontal and Other Studies with Clustered Samples Using the Method of Generalized Estimating Equations , 1997 .

[7]  A. Tamhane,et al.  Multiple Comparison Procedures , 1989 .

[8]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[9]  A. Lawrence Gould,et al.  Group sequential methods for clinical trials allowing early acceptance of Ho and incorporating costs , 1982 .

[10]  S J Pocock,et al.  Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. , 1992, Statistics in medicine.

[11]  J. Tucci,et al.  Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. , 1996, The American journal of medicine.

[12]  David L. DeMets,et al.  Sequential Comparison of Changes with Repeated Measurements Data , 1991 .

[13]  G. Andriole,et al.  The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.

[14]  Nanny Wermuth,et al.  A Simple Approximation for Bivariate and Trivariate Normal Integrals , 1991 .

[15]  L. Wurzinger,et al.  Methodological Errors in Medical Research , 1991 .

[16]  Repeated warnings re repeated measures. , 1986, Australian and New Zealand journal of medicine.